Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 15:171:174-177.
doi: 10.1016/j.amjcard.2022.02.007. Epub 2022 Mar 12.

Effect on Morbidity and Mortality of Direct Oral Anticoagulants in Patients With COVID-19

Ahmad A Toubasi  1
Affiliations

Effect on Morbidity and Mortality of Direct Oral Anticoagulants in Patients With COVID-19

Ahmad A Toubasi. Am J Cardiol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart
Figure 2
Figure 2
Hazard Ratio for the Association between DOACS use and COVID-19 Severity and Mortality.
Figure 3
Figure 3
Odds Ratio for the Association between DOACS use and COVID-19 Severity and Mortality.
See this image and copyright information in PMC

References

    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033–2040. - PMC - PubMed
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet 2020;395:1038] [published correction appears in Lancet 2020;395:1038] Lancet. 2020;395:1054–1062. - PMC - PubMed
    1. Flam B, Wintzell V, Ludvigsson JF, Mårtensson J, Pasternak B. Direct oral anticoagulant use and risk of severe COVID-19. J Intern Med. 2021;289:411–419. - PMC - PubMed
    1. Harrison RF, Forte K, Buscher MG, Jr, Chess A, Patel A, Moylan T, Mize CH, Werdmann M, Ferrigno R. The association of preinfection daily oral anticoagulation use and all-cause in hospital mortality from novel coronavirus 2019 at 21 days: a retrospective cohort study. Crit Care Explor. 2021;3:e0324. - PMC - PubMed
    1. Buenen AG, Sinkeldam M, Maas ML, Verdonschot M, Wever PC. Prior use of anticoagulation is associated with a better survival in COVID-19. J Thromb Thrombolysis. 2021;52:1207–1211. - PMC - PubMed